Latest News about TEVA
Recent news which mentions TEVA
From MarketWatch
Stock market is oversold — but investors don’t believe it yet
October 05, 2023
From MarketWatch
From Benzinga
Teva partnership with Sanofi ‘will pay dividends,’ analyst says
October 04, 2023
From MarketWatch
Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People
October 04, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
From Benzinga
Stocks are stuck in the breakdown lane and repairs will take time
September 28, 2023
From MarketWatch
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
September 27, 2023
From Benzinga
Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva
September 27, 2023
From Benzinga
Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report
September 26, 2023
From Benzinga
The bullish case for U.S. stocks is getting weaker
September 21, 2023
From MarketWatch
Stocks are trapped in a trading range. Something’s got to give.
September 14, 2023
From MarketWatch
3 No-Brainer Stocks to Buy With $20 Right Now
September 13, 2023
From Motley Fool
Why Can't You Find Adderall? Inside the Ongoing Shortage of ADHD Medication In US
September 12, 2023
Tickers
TEVA
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 11, 2023
From Benzinga
How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug
September 11, 2023
From Benzinga
Bristol Myers' Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug
September 07, 2023
From Benzinga
From Benzinga
Big Pharma Price-Fixing: Teva and Glenmark's $255M Settlement Shines Light on Industry Issues
August 22, 2023
Tickers
TEVA
From Benzinga
Zoom Video stock climbs after earnings, Activision Blizzard advances on Microsoft pact and other stocks on the move
August 22, 2023
From MarketWatch
FDA Greenlights Expanded Use Of Neurocrine Biosciences' Ingrezza: Analysts Weigh In Depression Warning
August 21, 2023
From Benzinga
Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged
August 10, 2023
From Benzinga
From Benzinga
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
August 02, 2023
From Benzinga
Tickers
TEVA
From Motley Fool
Humana, Waters, e.l.f. Beauty, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
August 02, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
